Abstract
Formalin-inactivated Venezuelan equine encephalomyelitis vaccine was prepared from virus propagated in rolling-bottle cultures of chicken embryo cells. The attenuated, TC-83 strain of virus was propagated in these cultures with a maintenance medium consisting of serum-free medium 199 containing 0.25% human serum albumin and antibiotics. By adjustment of maintenance medium volume (100 to 300 ml) and multiplicity of inoculum (0.04 to 0.00004), high-titered yields of virus were obtained with minimal cell destruction at convenient harvest times, viz, 18 to 24 h postinoculation. Inactivation of virus at 37 C was complete between 8 to 10 h with 0.05% Formalin and within 6 to 8 h with 0.1% Formalin. Antigen extinction potency tests in mice indicated that potent vaccines could be produced at both Formalin concentrations and, furthermore, that potency was not adversely affected by inactivation periods of up to 96 h.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cole F. E., Jr Inactivated eastern equine encephalomyelitis vaccine propagated in rolling-bottle cultures of chick embryo cells. Appl Microbiol. 1971 Nov;22(5):842–845. doi: 10.1128/am.22.5.842-845.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cole F. E., Jr, May S. W., Robinson D. M. Formalin-inactivated Venezuelan equine encephalomyelitis (Trinidad strain) vaccine produced in rolling-bottle cultures of chicken embryo cells. Appl Microbiol. 1973 Feb;25(2):262–265. doi: 10.1128/am.25.2.262-265.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cole F. E., Jr, McKinney R. W. Use of hamsters of potency assay of Eastern and Western equine encephalitis vaccines. Appl Microbiol. 1969 Jun;17(6):927–928. doi: 10.1128/am.17.6.927-928.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Darwish M. A., Hammon W. M. Studies on Japanese B encephalitis virus vaccine from tissue culture. VI. Development of a hamster kidney tissue culture inactivated vaccine for man. 4. Preparation and characterization of vaccine lot for human trial. Am J Trop Med Hyg. 1966 Sep;15(5):765–768. [PubMed] [Google Scholar]
- Darwish M. A., Hammon W. M. Studies on Japanese B encephalitis virus vaccines from tissue culture. 8. Formalin inactivated OCT-wild strain vaccine. J Immunol. 1966 Oct;97(4):506–511. [PubMed] [Google Scholar]
- Jahrling P. B., Scherer W. F. Homegeneity of Venezuelan encephalitis virion populations of hamster-virulent and benign strains, including the attenuated TC83 vaccine. Infect Immun. 1973 Jun;7(6):905–910. doi: 10.1128/iai.7.6.905-910.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MCKINNEY R. W., BERGE T. O., SAWYER W. D., TIGERTT W. D., CROZIER D. USE OF AN ATTENUATED STRAIN OF VENEZUELAN EQUINE ENCEPHALOMYELITIS VIRUS FOR IMMUNIZATION IN MAN. Am J Trop Med Hyg. 1963 Jul;12:597–603. doi: 10.4269/ajtmh.1963.12.597. [DOI] [PubMed] [Google Scholar]
- Pedersen C. E., Jr, Robinson D. M., Cole F. E., Jr Isolation of the vaccine strain of Venezuelan equine encephalomyelitis virus from mosquitoes in Louisiana. Am J Epidemiol. 1972 May;95(5):490–496. doi: 10.1093/oxfordjournals.aje.a121416. [DOI] [PubMed] [Google Scholar]
- Randall R., Mills J. W. FATAL ENCEPHALITIS IN MAN DUE TO THE VENEZUELAN VIRUS OF EQUINE ENCEPHALOMYELITIS IN TRINIDAD. Science. 1944 Mar 17;99(2568):225–226. doi: 10.1126/science.99.2568.225. [DOI] [PubMed] [Google Scholar]
- Spertzel R. O., McKinney R. W. Venezuelan equine encephalomyelitis in Central America and Mexico. Mil Med. 1972 Dec;137(12):441–445. [PubMed] [Google Scholar]